Back
Equinix, Inc. Vs. CRISPR Therapeutics AG Industry Stock Comparison
Buy
59
EQIX
Equinix, Inc.
Last Price:
$744.41
Seasonality Move:
-1.32%
Sell
42
CRSP
CRISPR Therapeutics AG
Last Price:
$54.84
Seasonality Move:
14.46%
Buy
59
Equinix, Inc. (EQIX)
is a Buy
Is Equinix, Inc. a Buy, Sell or Hold?
-
The current Equinix, Inc. [EQIX] share price is $744.08. The Score for EQIX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
EQIX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $54.84. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EQIX Stock Price Chart
What is Equinix, Inc.'s stock price today?
-
The Equinix, Inc. share price today is $744.08Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EQIX is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $54.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
EQIX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -9.73 | Sell |
| Relative Strength Index (14 RSI): | 42.48 | Sell |
| Chaikin Money Flow: | -427466 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (735.65 - 768.77) | Sell |
| Bollinger Bands (100): | (756.92 - 812.28) | Sell |
CRSP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.32 | Sell |
| Relative Strength Index (14 RSI): | 45.78 | Sell |
| Chaikin Money Flow: | -1252802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.68 - 56.94) | Buy |
| Bollinger Bands (100): | (52.47 - 65.41) | Sell |
EQIX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 748.88 | Sell |
| 20-day SMA: | 745.6 | Sell |
| 50-day SMA: | 787.23 | Sell |
| 200-day SMA: | 809.07 | Sell |
| 8-day EMA: | 748.54 | Sell |
| 20-day EMA: | 754.08 | Sell |
| 50-day EMA: | 772.17 | Sell |
| 200-day EMA: | 807.22 | Sell |
CRSP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.4 | Sell |
| 20-day SMA: | 54.72 | Buy |
| 50-day SMA: | 59.34 | Sell |
| 200-day SMA: | 51.04 | Buy |
| 8-day EMA: | 55.77 | Sell |
| 20-day EMA: | 55.78 | Sell |
| 50-day EMA: | 56.38 | Sell |
| 200-day EMA: | 37.38 | Buy |
Equinix, Inc. Earnings Growth & EQIX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.81 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.64 per share, and an increase next year of $0.12 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.09 per share, and an increase next year of $1.74 per share.
Equinix, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CRISPR Therapeutics AG Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||